Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

“No home to take methadone to”: Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston
Miriam Harris, Audrey M. Lambert, Ariel Maschke, et al.
Journal of Substance Abuse Treatment (2021) Vol. 135, pp. 108655-108655
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
Noa Krawczyk, Bianca Rivera, Emily Levin, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 3, pp. e238-e246
Open Access | Times Cited: 56
Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis
Kim Hoffman, Canyon Foot, Ximena A. Levander, et al.
Journal of Substance Abuse Treatment (2022) Vol. 141, pp. 108801-108801
Open Access | Times Cited: 51
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review
Alison E. Adams, Sarin Blawatt, Tianna Magel, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 18
Envisioning Minimally Disruptive Opioid Use Disorder Care
Honora Englander, Jessica Gregg, Ximena A. Levander
Journal of General Internal Medicine (2022) Vol. 38, Iss. 3, pp. 799-803
Open Access | Times Cited: 23
Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder
Ashish P. Thakrar, Jarratt D. Pytell, Kenneth B. Stoller, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 150, pp. 209055-209055
Open Access | Times Cited: 14
Examination of methadone involved overdoses during the COVID-19 pandemic
Daniel E. Kaufman, Amy L. Kennalley, Kenneth L. McCall, et al.
Forensic Science International (2023) Vol. 344, pp. 111579-111579
Open Access | Times Cited: 11
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder
Nicholas C. Cardamone, Rebecca E. Stewart, Kyle M. Kampman, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study
Melissa Davoust, Angela R. Bazzi, Samantha Blakemore, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
“You just want to kill the pain and get numb:” A mixed methods study investigating the lived experiences of individuals experiencing homelessness enrolled in outpatient methadone treatment
Marina Gaeta Gazzola, Emma Thompson, Kim Hoffman, et al.
Journal of Substance Use and Addiction Treatment (2025), pp. 209668-209668
Closed Access
Changes in Buprenorphine and Methadone Supplies in the US During the COVID-19 Pandemic
Annie Y. Chen, David Powell, Bradley D. Stein
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2223708-e2223708
Open Access | Times Cited: 16
Changes to methadone maintenance therapy in the United States, Canada, and Australia during the COVID-19 pandemic: A narrative review
Victoria Panwala, Paul J. Joudrey, Melanie Kowalski, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 152, pp. 209086-209086
Open Access | Times Cited: 10
Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland
Eshan U. Patel, Suzanne M. Grieb, Abigail K. Winiker, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey
Sarah Brothers, Adam Palayew, Caty Simon, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7
“It didn’t hurt me”: patients’ and providers’ perspectives on unsupervised take-home doses, drug diversion, and overdose risks in the provision of medication for opioid use disorder during COVID-19 in San Juan, Puerto Rico
Roberto Abadie, Celia B. Fisher
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences
Rebecca McDonald, Anne Berit Bech, Thomas Clausen
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
“And Then COVID Hits”: A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19
Calla Harrington, Amelia Bailey, Elizabeth Delorme, et al.
Substance Use & Misuse (2022) Vol. 58, Iss. 2, pp. 266-274
Open Access | Times Cited: 9
Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore
Tolulope M. Abidogun, Thomas O. Cole, Ebonie Massey, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 145, pp. 208946-208946
Open Access | Times Cited: 5
Enumerating contributions of fentanyls and other factors to the unprecedented 2020 rise in opioid overdose deaths: model-based analysis
Erin J. Stringfellow, Tse Yang Lim, Catherine DiGennaro, et al.
PNAS Nexus (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 5
A Scoping Review on the Effects of COVID-19 on Syringe Service Programs in the United States
Dylan Pietrantoni, Crystal Barroca, Sarah Lynch, et al.
Cureus (2023)
Open Access | Times Cited: 4
Opioid use and COVID-19: a secondary analysis of the impact of relaxation of methadone take-home dosing guidelines on use of illicit opioids
Victoria Panwala, Emily Thorn, Solmaz Amiri, et al.
The American Journal of Drug and Alcohol Abuse (2023) Vol. 49, Iss. 5, pp. 597-605
Closed Access | Times Cited: 3
Rates and Correlates of Alcohol and Substance Use Among Women Veterans During the COVID-19 Pandemic: The Moderating Role of COVID-Specific Anxiety
Katherine A. Buckheit, Carrie Pengelly, Abigail E. Ramon, et al.
Women s Health Issues (2023) Vol. 33, Iss. 3, pp. 250-257
Open Access | Times Cited: 2
Impacts of the COVID-19 Pandemic on a Rural Opioid Support Services Program
J. E. Walters, Aubrey Jones, Aaron Brown, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 18, pp. 11164-11164
Open Access | Times Cited: 3
Patient and Clinician Experiences with the Implementation of Telemedicine and Related Adaptations in Office-Based Buprenorphine Treatment During the COVID-19 Pandemic: A Qualitative Study
Melissa Davoust, Angela R. Bazzi, Samantha Blakemore, et al.
Research Square (Research Square) (2024)
Open Access
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder
Nicholas C. Cardamone, Rebecca E. Stewart, Kyle M. Kampman, et al.
Research Square (Research Square) (2024)
Open Access
Flexible delivery of opioid agonist treatment during COVID-19 in Norway: A cross-sectional survey of provider experiences
Rebecca McDonald, Anne Berit Bech, Thomas Clausen
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top